Novel uses of ketamine in the emergency department.
Brian N CorwellSergey M MotovNatalie L DavisHong K KimPublished in: Expert opinion on drug safety (2022)
Ketamine is an effective adjunct to opioids, providing greater pain relief than morphine alone. Ketamine (0.1-0.3 mg/kg IV) alone can provide analgesia similar to that of morphine in patients with acute visceral and musculoskeletal pain, as well as for chronic painful conditions (cancer, vaso-occlusive pain crisis associated with sickle cell disease, and in patients with high opioid tolerance and/or opioid dependency). Available literature shows that ketamine (1-2 mg/kg IV or 4-5 mg/kg IM) is a safe, rapid (<5 minutes) and effective tranquilization agent for ED patients with acute agitation. Finally, there is growing evidence that suggests ketamine may have potential utility in the management of patients with self-harm ideation or acute depressive episodes. Intravenous infusion of ketamine (0.5 mg/kg over 40 mins) has been shown to produce an antidepressant effect and decrease in suicidal ideation within 4 hours with effects lasting up to one week.
Keyphrases
- pain management
- chronic pain
- emergency department
- systematic review
- public health
- liver failure
- low dose
- depressive symptoms
- squamous cell carcinoma
- risk assessment
- papillary thyroid
- skeletal muscle
- young adults
- quantum dots
- spinal cord injury
- spinal cord
- neuropathic pain
- respiratory failure
- study protocol
- stress induced
- hepatitis b virus
- human health